Patent US5563124A successfully refreshed from Google Patents.
US5563124A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Osteogenic product and process
Assignee: Zimmer Orthobiologics Inc
•
Filing: 1993-11-16
•
Granted: 1996-10-08
•
Expires: 2013-11-16
Abstract
Abstract Disclosed is a product which includes calcium carbonate and bone growth factor useful for the promotion of bone formation when implanted in the body. The calcium carbonate is preferably in the form of aragonite which can be recovered from naturally occurring coral. A preferred bone growth factor of the present invention is a protein mixture purified from bone. Also disclosed is a process for the induction of bone formation which includes implanting the product in a body. The product and process of the present invention are particularly useful in hip replacement operations, knee replacement operations, spinal fusion operations, repair of periodontal defects, treatment of osteoporosis, repair of bone tumor defects and repair of bone fractures.
Inventors
- 👤 Christopher J. Damien
- 👤 James J. Benedict
- 👤 James W. Poser
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 15:15
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/14; A61L27/22; A61L27/227; A61F; A61F2/00; A61F2/02; A61F2/28; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/18; A61K38/1875; A61L27/02; A61L27/025; A61P; A61P1/00; A61P1/02; A61P19/00; A61P19/08; A61P19/10; A61P43/00; C; C07; C07K; C07K14/00; C07K14/435; C07K14/475; C07K14/51; A61F2/30; A61F2/32; A61F2/38; A61F2/44; A61F2/4455; A61F2002/30001; A61F2002/30003; A61F2002/30004; A61F2002/30011; A61F2002/3006; A61F2002/30062; A61F2210/00; A61F2210/0004; A61F2250/00; A61F2250/0014; A61F2250/0023
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
10 words
An osteogenic product, comprising aragonite and a bone growth factor.
Claim 2
Dependent Claim
10 words
An osteogenic product, comprising aragonite and a bone growth factor.
Claim 3
Dependent Claim
24 words
An osteogenic product as claimed in claim 1, further comprising a material selected from the group consisting of collagen, fibrin, alginate and mixtures thereof.
Claim 4
Dependent Claim
32 words
An osteogenic product as claimed in claim 1, wherein said bone growth factor is selected from the group consisting of purified bone growth factors, recombinantly produced bone growth factors and mixtures thereof.
Claim 5
Dependent Claim
71 words
An osteogenic product as claimed in claim 1, wherein said bone growth factor comprises an amino acid composition of from about 20.7 to about 26.1 mole percent acidic amino acids, about 11.3 to about 15.7 mole percent hydroxy amino acids, about 37.6 to about 42.4 mole percent aliphatic amino acids, about 5.8 to about 7.9 mole percent aromatic amino acids and about 13.3 to about 19.9 mole percent basic amino acids.
Claim 6
Dependent Claim
92 words
An osteogenic product as claimed in claim 1, wherein said bone growth factor comprises, upon hydrolysis, an amino acid composition of from about 20.7 to about 26.1 mole percent ASP(+ASN) and GLU(+GLN); from about 11.3 to about 15.7 mole percent SER and THR; from about 37.6 to about 42.4 mole percent ALA, GLY, PRO, MET, VAL, ILE, and LEU; from about 5.8 to about 7.9 mole percent TYR and PHE; and from about 13.3 to about 19.9 mole percent HIS, ARG, and LYS, based on the total moles of said amino acids.
Claim 7
Dependent Claim
28 words
An osteogenic product as claimed in claim 1, wherein said product comprises between about 10 micrograms bone growth factor/g aragonite and about 1000 micrograms bone growth factor/g aragonite.
Claim 8
Dependent Claim
15 words
An osteogenic product as claimed in claim 1, wherein said aragonite is in particulate form.
Claim 9
Dependent Claim
18 words
An osteogenic product as claimed in claim 1, wherein said aragonite is in the form of a block.
Claim 10
Dependent Claim
22 words
A process for the induction of bone formation, comprising implanting a product, wherein said product comprises aragonite and a bone growth factor.
Claim 11
Dependent Claim
22 words
A process for the induction of bone formation, comprising implanting a product, wherein said product comprises aragonite and a bone growth factor.
Claim 12
Dependent Claim
25 words
A process as claimed in claim 9 wherein said product further comprises material selected from the group consisting of collagen, fibrin, alginate and mixtures thereof.
Claim 13
Dependent Claim
31 words
A process as claimed in claim 9, wherein said bone growth factor is selected from the group consisting of purified bone growth factors, recombinantly produced bone growth factors and mixtures thereof.
Claim 14
Dependent Claim
70 words
A process as claimed in claim 9, wherein said bone growth factor comprises an amino acid composition of from about 20.7 to about 26.1 mole percent acidic amino acids, about 11.3 to about 15.7 mole percent hydroxy amino acids, about 37.6 to about 42.4 mole percent aliphatic amino acids, about 5.8 to about 7.9 mole percent aromatic amino acids and about 13.3 to about 19.9 mole percent basic amino acids.
Claim 15
Dependent Claim
91 words
A process as claimed in claim 9, wherein said bone growth factor comprises, upon hydrolysis, an amino acid composition of from about 20.7 to about 26.1 mole percent ASP(+ASN) and GLU(+GLN); from about 11.3 to about 15.7 mole percent SER and THR; from about 37.6 to about 42.4 mole percent ALA, GLY, PRO, MET, VAL, ILE, and LEU; from about 5.8 to about 7.9 mole percent TYR and PHE; and from about 13.3 to about 19.9 mole percent HIS, ARG, and LYS, based on the total moles of said amino acids.
Claim 16
Dependent Claim
27 words
A process as claimed in claim 9, wherein said product comprises between about 10 micrograms bone growth factor/g aragonite and about 1000 micrograms bone growth factor/g aragonite.
Claim 17
Dependent Claim
14 words
A process as claimed in claim 9, wherein said aragonite is in particulate form.
Claim 18
Dependent Claim
17 words
A process as claimed in claim 9, wherein said aragonite is in the form of a block.
Claim 19
Dependent Claim
41 words
A process as claimed in claim 9, wherein said process is selected from the group consisting of hip replacement operation, knee replacement operation, spinal fusion, repair of periodontal defects, treatment of osteoporosis, repair of bone defects and repair of bone fractures.
Claim 20
Dependent Claim
46 words
A process as claimed in claim 9, wherein said process is a hip replacement operation involving the implantation of an artificial hip; said aragonite is in particulate form; and said product is positioned between bone and either the ball or socket portion of the artificial hip.
References Cited (Backward Citations)
US3318774A
Cited
US3458397A
Cited
US4356572A
Cited
US4361471A
Cited
US4761471A
Cited
US4294753A
Cited
US4789732A
Cited
US4455256A
Cited
US4619989A
Cited
US4394370A
Cited
US4440750A
Cited
US4774277A
Cited
US4434094A
Cited
US4795804A
Cited
US4804744A
Cited
US4608199A
Cited
US4596574A
Cited
US4620327A
Cited
US4789663A
Cited
US4627982A
Cited
US4774228A
Cited
US4774322A
Cited
US4810691A
Cited
US4843063A
Cited
US4637931A
Cited
US4888366A
Cited
US5001169A
Cited
US4563350A
Cited
US4992226A
Cited
US4795467A
Cited
US4627853A
Cited
US4681763A
Cited
US4975527A
Cited
US5106748A
Cited
US4743259A
Cited
US4877864A
Cited
US4863732A
Cited
US4968590A
Cited
US4975526A
Cited
US5158934A
Cited
US5290763A
Cited
US5270300A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-10-08 | 2000-04-08 | 2000-10-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-10-08 | 2004-04-08 | 2004-10-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-10-08 | 2008-04-08 | 2008-10-08 | $7700.00 | Window Closed / Lapsed |